The global Cardiovascular and Cerebrovascular API revenue was US$ 3072.7 million in 2022 and is forecast to a readjusted size of US$ 3710.9 million by 2029 with a CAGR of 2.7% during the forecast period (2023-2029).

and India Cardiovascular and Cerebrovascular API Market

Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.

In India, the Cardiovascular and Cerebrovascular API revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.

The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.

This report focuses on global and India Cardiovascular and Cerebrovascular API market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Cardiovascular and Cerebrovascular API will continue to grow rapidly in the future.

Global Cardiovascular and Cerebrovascular API Scope and Market Size

Cardiovascular and Cerebrovascular API market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Cardiovascular and Cerebrovascular API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Cardiovascular and Cerebrovascular API market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Cardiovascular and Cerebrovascular API Market Report

Report Metric	Details
Report Name	and India Cardiovascular and Cerebrovascular API Market
Forecasted market size in 2029	US$ 3710.9 million
CAGR	2.7%
Forecasted years	2023 - 2029
Segment by Type	Sartans Cardiovascular and Cerebrovascular API Statins Cardiovascular and Cerebrovascular API Puri Cardiovascular and Cerebrovascular API
Segment by Application	Oral Drugs Injection Drugs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Cardiovascular and Cerebrovascular API Market size in 2029?

Ans: The and India Cardiovascular and Cerebrovascular API Market size in 2029 will be US$ 3710.9 million.

What is the and India Cardiovascular and Cerebrovascular API Market production share by region?

Ans: China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.

What is the and India Cardiovascular and Cerebrovascular API Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Cardiovascular and Cerebrovascular API Market report?

Ans: The main players in the and India Cardiovascular and Cerebrovascular API Market are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences

What are the Application segmentation covered in the and India Cardiovascular and Cerebrovascular API Market report?

Ans: The Applications covered in the and India Cardiovascular and Cerebrovascular API Market report are Oral Drugs, Injection Drugs

What are the Type segmentation covered in the and India Cardiovascular and Cerebrovascular API Market report?

Ans: The Types covered in the and India Cardiovascular and Cerebrovascular API Market report are Sartans Cardiovascular and Cerebrovascular API, Statins Cardiovascular and Cerebrovascular API, Puri Cardiovascular and Cerebrovascular API

1 Study Coverage

1.1 Cardiovascular and Cerebrovascular API Product Introduction

1.2 Global Cardiovascular and Cerebrovascular API Outlook 2018 VS 2022 VS 2029

1.2.1 Global Cardiovascular and Cerebrovascular API Sales in US$ Million for the Year 2018-2029

1.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume for the Year 2018-2029

1.3 India Cardiovascular and Cerebrovascular API Outlook 2018 VS 2022 VS 2029

1.3.1 India Cardiovascular and Cerebrovascular API Sales in US$ Million for the Year 2018-2029

1.3.2 India Cardiovascular and Cerebrovascular API Sales in Volume for the Year 2018-2029

1.4 Cardiovascular and Cerebrovascular API Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Cardiovascular and Cerebrovascular API in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Cardiovascular and Cerebrovascular API Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Cardiovascular and Cerebrovascular API Market Dynamics

1.5.1 Cardiovascular and Cerebrovascular API Industry Trends

1.5.2 Cardiovascular and Cerebrovascular API Market Drivers

1.5.3 Cardiovascular and Cerebrovascular API Market Challenges

1.5.4 Cardiovascular and Cerebrovascular API Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Cardiovascular and Cerebrovascular API by Type

2.1 Cardiovascular and Cerebrovascular API Market Segment by Type

2.1.1 Sartans Cardiovascular and Cerebrovascular API

2.1.2 Statins Cardiovascular and Cerebrovascular API

2.1.3 Puri Cardiovascular and Cerebrovascular API

2.2 Global Cardiovascular and Cerebrovascular API Market Size by Type

2.2.1 Global Cardiovascular and Cerebrovascular API Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Cardiovascular and Cerebrovascular API Market Size by Type

2.3.1 India Cardiovascular and Cerebrovascular API Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Cardiovascular and Cerebrovascular API by Application

3.1 Cardiovascular and Cerebrovascular API Market Segment by Application

3.1.1 Oral Drugs

3.1.2 Injection Drugs

3.2 Global Cardiovascular and Cerebrovascular API Market Size by Application

3.2.1 Global Cardiovascular and Cerebrovascular API Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Cardiovascular and Cerebrovascular API Market Size by Application

3.3.1 India Cardiovascular and Cerebrovascular API Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Cardiovascular and Cerebrovascular API Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Cardiovascular and Cerebrovascular API Competitor Landscape by Company

4.1 Global Cardiovascular and Cerebrovascular API Market Size by Company

4.1.1 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Ranked by Revenue (2022)

4.1.2 Global Cardiovascular and Cerebrovascular API Revenue by Manufacturer (2018-2023)

4.1.3 Global Cardiovascular and Cerebrovascular API Sales by Manufacturer (2018-2023)

4.1.4 Global Cardiovascular and Cerebrovascular API Price by Manufacturer (2018-2023)

4.2 Global Cardiovascular and Cerebrovascular API Concentration Ratio (CR)

4.2.1 Cardiovascular and Cerebrovascular API Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cardiovascular and Cerebrovascular API in 2022

4.2.3 Global Cardiovascular and Cerebrovascular API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Product Offered and Application

4.5 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Cardiovascular and Cerebrovascular API Market Size by Company

4.7.1 Key Players of Cardiovascular and Cerebrovascular API in India, Ranked by Revenue (2022)

4.7.2 India Cardiovascular and Cerebrovascular API Revenue by Players (2018-2023)

4.7.3 India Cardiovascular and Cerebrovascular API Sales by Players (2018-2023)

5 Global Cardiovascular and Cerebrovascular API Market Size by Region

5.1 Global Cardiovascular and Cerebrovascular API Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Cardiovascular and Cerebrovascular API Market Size in Volume by Region (2018-2029)

5.2.1 Global Cardiovascular and Cerebrovascular API Sales in Volume by Region: 2018-2023

5.2.2 Global Cardiovascular and Cerebrovascular API Sales in Volume Forecast by Region (2024-2029)

5.3 Global Cardiovascular and Cerebrovascular API Market Size in Value by Region (2018-2029)

5.3.1 Global Cardiovascular and Cerebrovascular API Sales in Value by Region: 2018-2023

5.3.2 Global Cardiovascular and Cerebrovascular API Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Cardiovascular and Cerebrovascular API Market Size YoY Growth 2018-2029

6.2 Americas Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Cardiovascular and Cerebrovascular API Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Cardiovascular and Cerebrovascular API Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Cardiovascular and Cerebrovascular API Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Cardiovascular and Cerebrovascular API Market Size YoY Growth 2018-2029

7.2 EMEA Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Cardiovascular and Cerebrovascular API Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Cardiovascular and Cerebrovascular API Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Cardiovascular and Cerebrovascular API Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Cardiovascular and Cerebrovascular API Market Size YoY Growth 2018-2029

8.2 China Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Cardiovascular and Cerebrovascular API Market Size YoY Growth 2018-2029

9.2 APAC Cardiovascular and Cerebrovascular API Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Cardiovascular and Cerebrovascular API Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Cardiovascular and Cerebrovascular API Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Cardiovascular and Cerebrovascular API Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Cardiovascular and Cerebrovascular API Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Zhuhai Rundu Pharmaceutical

10.1.1 Zhuhai Rundu Pharmaceutical Company Information

10.1.2 Zhuhai Rundu Pharmaceutical Description and Business Overview

10.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

10.1.5 Zhuhai Rundu Pharmaceutical Recent Development

10.2 Ningbo Menovo Pharmaceutical

10.2.1 Ningbo Menovo Pharmaceutical Company Information

10.2.2 Ningbo Menovo Pharmaceutical Description and Business Overview

10.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

10.2.5 Ningbo Menovo Pharmaceutical Recent Development

10.3 Zhejiang Huahai Pharmaceutical

10.3.1 Zhejiang Huahai Pharmaceutical Company Information

10.3.2 Zhejiang Huahai Pharmaceutical Description and Business Overview

10.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

10.3.5 Zhejiang Huahai Pharmaceutical Recent Development

10.4 Zhejiang Tianyu Pharmaceutical

10.4.1 Zhejiang Tianyu Pharmaceutical Company Information

10.4.2 Zhejiang Tianyu Pharmaceutical Description and Business Overview

10.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

10.4.5 Zhejiang Tianyu Pharmaceutical Recent Development

10.5 Zhejiang Hisun Pharmaceutical

10.5.1 Zhejiang Hisun Pharmaceutical Company Information

10.5.2 Zhejiang Hisun Pharmaceutical Description and Business Overview

10.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

10.5.5 Zhejiang Hisun Pharmaceutical Recent Development

10.6 Zhejiang Lepu Pharmaceutical

10.6.1 Zhejiang Lepu Pharmaceutical Company Information

10.6.2 Zhejiang Lepu Pharmaceutical Description and Business Overview

10.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

10.6.5 Zhejiang Lepu Pharmaceutical Recent Development

10.7 Zhejiang Jiangbei Pharmaceutical

10.7.1 Zhejiang Jiangbei Pharmaceutical Company Information

10.7.2 Zhejiang Jiangbei Pharmaceutical Description and Business Overview

10.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

10.7.5 Zhejiang Jiangbei Pharmaceutical Recent Development

10.8 DR.Reddy

10.8.1 DR.Reddy Company Information

10.8.2 DR.Reddy Description and Business Overview

10.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.8.4 DR.Reddy Cardiovascular and Cerebrovascular API Products Offered

10.8.5 DR.Reddy Recent Development

10.9 Glenmerk

10.9.1 Glenmerk Company Information

10.9.2 Glenmerk Description and Business Overview

10.9.3 Glenmerk Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Glenmerk Cardiovascular and Cerebrovascular API Products Offered

10.9.5 Glenmerk Recent Development

10.10 Cipla

10.10.1 Cipla Company Information

10.10.2 Cipla Description and Business Overview

10.10.3 Cipla Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Cipla Cardiovascular and Cerebrovascular API Products Offered

10.10.5 Cipla Recent Development

10.11 MSN Life Sciences

10.11.1 MSN Life Sciences Company Information

10.11.2 MSN Life Sciences Description and Business Overview

10.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2018-2023)

10.11.4 MSN Life Sciences Cardiovascular and Cerebrovascular API Products Offered

10.11.5 MSN Life Sciences Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Cardiovascular and Cerebrovascular API Industry Chain Analysis

11.2 Cardiovascular and Cerebrovascular API Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Cardiovascular and Cerebrovascular API Production Mode & Process

11.4 Cardiovascular and Cerebrovascular API Sales and Marketing

11.4.1 Cardiovascular and Cerebrovascular API Sales Channels

11.4.2 Cardiovascular and Cerebrovascular API Distributors

11.5 Cardiovascular and Cerebrovascular API Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Zhuhai Rundu Pharmaceutical

Ningbo Menovo Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Tianyu Pharmaceutical

Zhejiang Hisun Pharmaceutical

Zhejiang LEPU Pharmaceutical

Zhejiang Jiangbei Pharmaceutical

List of Tables

Table 1. Cardiovascular and Cerebrovascular API CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Cardiovascular and Cerebrovascular API Market Trends

Table 3. Cardiovascular and Cerebrovascular API Market Drivers

Table 4. Cardiovascular and Cerebrovascular API Market Challenges

Table 5. Cardiovascular and Cerebrovascular API Market Restraints

Table 6. Global Cardiovascular and Cerebrovascular API Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Cardiovascular and Cerebrovascular API Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Cardiovascular and Cerebrovascular API Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Cardiovascular and Cerebrovascular API Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Cardiovascular and Cerebrovascular API Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Cardiovascular and Cerebrovascular API Revenue Share by Manufacturer, 2018-2023

Table 13. Global Cardiovascular and Cerebrovascular API Sales by Manufacturer, (MT), 2018-2023

Table 14. Global Cardiovascular and Cerebrovascular API Sales Share by Manufacturer, 2018-2023

Table 15. Global Cardiovascular and Cerebrovascular API Price by Manufacturer (2018-2023) & (USD/Kg)

Table 16. Global Cardiovascular and Cerebrovascular API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Cardiovascular and Cerebrovascular API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular API as of 2022)

Table 18. Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Product Offered and Application

Table 20. Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Cardiovascular and Cerebrovascular API in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Cardiovascular and Cerebrovascular API Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Cardiovascular and Cerebrovascular API Revenue Share by Players, (2018-2023)

Table 25. India Cardiovascular and Cerebrovascular API Sales by Players, (MT), (2018-2023)

Table 26. India Cardiovascular and Cerebrovascular API Sales Share by Players, (2018-2023)

Table 27. Global Cardiovascular and Cerebrovascular API Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Cardiovascular and Cerebrovascular API Sales in Volume by Region (2018-2023) & (MT)

Table 29. Global Cardiovascular and Cerebrovascular API Sales in Volume Forecast by Region (2024-2029) & (MT)

Table 30. Global Cardiovascular and Cerebrovascular API Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Cardiovascular and Cerebrovascular API Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Cardiovascular and Cerebrovascular API Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Cardiovascular and Cerebrovascular API Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Cardiovascular and Cerebrovascular API Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Cardiovascular and Cerebrovascular API Sales in Volume by Country (2018-2023) & (MT)

Table 36. Americas Cardiovascular and Cerebrovascular API Sales in Volume by Country (2024-2029) & (MT)

Table 37. EMEA Cardiovascular and Cerebrovascular API Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Cardiovascular and Cerebrovascular API Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Cardiovascular and Cerebrovascular API Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Cardiovascular and Cerebrovascular API Sales in Volume by Country (2018-2023) & (MT)

Table 41. EMEA Cardiovascular and Cerebrovascular API Sales in Volume by Country (2024-2029) & (MT)

Table 42. APAC Cardiovascular and Cerebrovascular API Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Cardiovascular and Cerebrovascular API Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Cardiovascular and Cerebrovascular API Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Cardiovascular and Cerebrovascular API Sales in Volume by Country (2018-2023) & (MT)

Table 46. APAC Cardiovascular and Cerebrovascular API Sales in Volume by Country (2024-2029) & (MT)

Table 47. Zhuhai Rundu Pharmaceutical Company Information

Table 48. Zhuhai Rundu Pharmaceutical Description and Business Overview

Table 49. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 50. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 51. Zhuhai Rundu Pharmaceutical Recent Development

Table 52. Ningbo Menovo Pharmaceutical Company Information

Table 53. Ningbo Menovo Pharmaceutical Description and Business Overview

Table 54. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 55. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 56. Ningbo Menovo Pharmaceutical Recent Development

Table 57. Zhejiang Huahai Pharmaceutical Company Information

Table 58. Zhejiang Huahai Pharmaceutical Description and Business Overview

Table 59. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 60. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 61. Zhejiang Huahai Pharmaceutical Recent Development

Table 62. Zhejiang Tianyu Pharmaceutical Company Information

Table 63. Zhejiang Tianyu Pharmaceutical Description and Business Overview

Table 64. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 65. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 66. Zhejiang Tianyu Pharmaceutical Recent Development

Table 67. Zhejiang Hisun Pharmaceutical Company Information

Table 68. Zhejiang Hisun Pharmaceutical Description and Business Overview

Table 69. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 70. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 71. Zhejiang Hisun Pharmaceutical Recent Development

Table 72. Zhejiang Lepu Pharmaceutical Company Information

Table 73. Zhejiang Lepu Pharmaceutical Description and Business Overview

Table 74. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 75. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 76. Zhejiang Lepu Pharmaceutical Recent Development

Table 77. Zhejiang Jiangbei Pharmaceutical Company Information

Table 78. Zhejiang Jiangbei Pharmaceutical Description and Business Overview

Table 79. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 80. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 81. Zhejiang Jiangbei Pharmaceutical Recent Development

Table 82. DR.Reddy Company Information

Table 83. DR.Reddy Description and Business Overview

Table 84. DR.Reddy Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 85. DR.Reddy Cardiovascular and Cerebrovascular API Product

Table 86. DR.Reddy Recent Development

Table 87. Glenmerk Company Information

Table 88. Glenmerk Description and Business Overview

Table 89. Glenmerk Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 90. Glenmerk Cardiovascular and Cerebrovascular API Product

Table 91. Glenmerk Recent Development

Table 92. Cipla Company Information

Table 93. Cipla Description and Business Overview

Table 94. Cipla Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 95. Cipla Cardiovascular and Cerebrovascular API Product

Table 96. Cipla Recent Development

Table 97. MSN Life Sciences Company Information

Table 98. MSN Life Sciences Description and Business Overview

Table 99. MSN Life Sciences Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 100. MSN Life Sciences Cardiovascular and Cerebrovascular API Product

Table 101. MSN Life Sciences Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Cardiovascular and Cerebrovascular API Customers List

Table 105. Cardiovascular and Cerebrovascular API Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Cardiovascular and Cerebrovascular API Product Picture

Figure 2. Global Cardiovascular and Cerebrovascular API Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Cardiovascular and Cerebrovascular API Market Size 2018-2029 (US$ Million)

Figure 4. Global Cardiovascular and Cerebrovascular API Sales 2018-2029 (MT)

Figure 5. India Cardiovascular and Cerebrovascular API Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Cardiovascular and Cerebrovascular API Market Size 2018-2029 (US$ Million)

Figure 7. India Cardiovascular and Cerebrovascular API Sales 2018-2029 (MT)

Figure 8. India Cardiovascular and Cerebrovascular API Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Cardiovascular and Cerebrovascular API Market Share in Global, in Volume (MT) 2018-2029

Figure 10. Cardiovascular and Cerebrovascular API Report Years Considered

Figure 11. Product Picture of Sartans Cardiovascular and Cerebrovascular API

Figure 12. Product Picture of Statins Cardiovascular and Cerebrovascular API

Figure 13. Product Picture of Puri Cardiovascular and Cerebrovascular API

Figure 14. Global Cardiovascular and Cerebrovascular API Market Share by Type in 2022 & 2029

Figure 15. Global Cardiovascular and Cerebrovascular API Sales in Value by Type (2018-2029) & (US$ Million)

Figure 16. Global Cardiovascular and Cerebrovascular API Sales Market Share in Value by Type (2018-2029)

Figure 17. Global Cardiovascular and Cerebrovascular API Sales by Type (2018-2029) & (MT)

Figure 18. Global Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2018-2029)

Figure 19. Global Cardiovascular and Cerebrovascular API Price by Type (2018-2029) & (USD/Kg)

Figure 20. India Cardiovascular and Cerebrovascular API Market Share by Type in 2022 & 2029

Figure 21. India Cardiovascular and Cerebrovascular API Sales in Value by Type (2018-2029) & (US$ Million)

Figure 22. India Cardiovascular and Cerebrovascular API Sales Market Share in Value by Type (2018-2029)

Figure 23. India Cardiovascular and Cerebrovascular API Sales by Type (2018-2029) & (MT)

Figure 24. India Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2018-2029)

Figure 25. India Cardiovascular and Cerebrovascular API Price by Type (2018-2029) & (USD/Kg)

Figure 26. Product Picture of Oral Drugs

Figure 27. Product Picture of Injection Drugs

Figure 28. Global Cardiovascular and Cerebrovascular API Market Share by Application in 2022 & 2029

Figure 29. Global Cardiovascular and Cerebrovascular API Sales in Value by Application (2018-2029) & (US$ Million)

Figure 30. Global Cardiovascular and Cerebrovascular API Sales Market Share in Value by Application (2018-2029)

Figure 31. Global Cardiovascular and Cerebrovascular API Sales by Application (2018-2029) & (MT)

Figure 32. Global Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2018-2029)

Figure 33. Global Cardiovascular and Cerebrovascular API Price by Application (2018-2029) & (USD/Kg)

Figure 34. India Cardiovascular and Cerebrovascular API Market Share by Application in 2022 & 2029

Figure 35. India Cardiovascular and Cerebrovascular API Sales in Value by Application (2018-2029) & (US$ Million)

Figure 36. India Cardiovascular and Cerebrovascular API Sales Market Share in Value by Application (2018-2029)

Figure 37. India Cardiovascular and Cerebrovascular API Sales by Application (2018-2029) & (MT)

Figure 38. India Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2018-2029)

Figure 39. India Cardiovascular and Cerebrovascular API Price by Application (2018-2029) & (USD/Kg)

Figure 40. Americas Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2018-2029 (MT)

Figure 41. Americas Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 42. Americas Cardiovascular and Cerebrovascular API Sales by Type (2018-2029) & (MT)

Figure 43. Americas Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2018-2029)

Figure 44. Americas Cardiovascular and Cerebrovascular API Sales by Application (2018-2029) & (MT)

Figure 45. Americas Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2018-2029)

Figure 46. United States Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 47. Canada Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Mexico Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. Brazil Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. EMEA Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2018-2029 (MT)

Figure 51. EMEA Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 52. EMEA Cardiovascular and Cerebrovascular API Sales by Type (2018-2029) & (MT)

Figure 53. EMEA Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2018-2029)

Figure 54. EMEA Cardiovascular and Cerebrovascular API Sales by Application (2018-2029) & (MT)

Figure 55. EMEA Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2018-2029)

Figure 56. Europe Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 57. Middle East Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. Africa Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 59. China Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2018-2029 (MT)

Figure 60. China Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 61. China Cardiovascular and Cerebrovascular API Sales by Type (2018-2029) & (MT)

Figure 62. China Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2018-2029)

Figure 63. China Cardiovascular and Cerebrovascular API Sales by Application (2018-2029) & (MT)

Figure 64. China Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2018-2029)

Figure 65. APAC Cardiovascular and Cerebrovascular API Sales in Volume Growth Rate 2018-2029 (MT)

Figure 66. APAC Cardiovascular and Cerebrovascular API Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 67. APAC Cardiovascular and Cerebrovascular API Sales by Type (2018-2029) & (MT)

Figure 68. APAC Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Type (2018-2029)

Figure 69. APAC Cardiovascular and Cerebrovascular API Sales by Application (2018-2029) & (MT)

Figure 70. APAC Cardiovascular and Cerebrovascular API Sales Market Share in Volume by Application (2018-2029)

Figure 71. Japan Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 72. South Korea Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. China Taiwan Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. Southeast Asia Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. India Cardiovascular and Cerebrovascular API Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. Cardiovascular and Cerebrovascular API Value Chain

Figure 77. Cardiovascular and Cerebrovascular API Production Process

Figure 78. Channels of Distribution

Figure 79. Distributors Profiles

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

Figure 82. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22I19939

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38W19812

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-39V16824

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions